14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
GNL vs SBRA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Sabra Healthcare REIT, Inc. (SBRA) is the stronger overall head-to-head candidate over Global Net Lease, Inc. (GNL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). GNL carries a Unified Composite Score of 29.1/100 (SELL) at $6.28 (N/M Forward P/E, 34.8% operating margin), whereas SBRA carries 58.3/100 (HOLD) at $20.25 (30.4x Forward P/E, 18.4% operating margin).
Technical & Structure Timing Caution: GNL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.0); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNL vs SBRA. Trailing 12-month operating profitability (GNL 34.8% vs SBRA 18.4%) and valuation multiples (GNL N/M vs SBRA 30.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment31.2% of Rev ($288M)
90D Engineering Disclosures0 Published
Investor FAQ GNL vs SBRA Key Questions & Quantitative Answers
As of Nov 17, 2026, Sabra Healthcare REIT, Inc. (SBRA) is the stronger overall head-to-head candidate over Global Net Lease, Inc. (GNL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). GNL carries a Unified Composite Score of 29.1/100 (SELL) at $6.28 (N/M Forward P/E, 34.8% operating margin), whereas SBRA carries 58.3/100 (HOLD) at $20.25 (30.4x Forward P/E, 18.4% operating margin). Technical & Structure Timing Caution: GNL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.0); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SBRA leads the Growth & Scale pillar: GNL posts -6.7% YoY revenue growth and +333.0% YoY earnings growth on $452M TTM revenue (86.7% gross margin, 34.8% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). On trailing 12-month operating scale, GNL generates $452M in USD-normalized revenue versus $924M for SBRA. In operating R&D and SG&A reinvestment, GNL deploys 51.9% of Rev ($234M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.
SBRA screens cheaper on headline valuation multiples. GNL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (73.5% EBITDA margin), whereas SBRA trades at 30.4x Forward P/E, 75.7x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GNL (-0.8% ROE) versus SBRA (2.5% ROE) capital efficiency.
In options market volatility and institutional positioning, GNL carries 204.7% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.21β · 29% Vol realized risk). By comparison, SBRA carries 27.4% implied volatility (17th %ile, Compressed (<25th %ile)), a 0.19x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.00β · 30% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.